Middle East and Africa Biobanks Market

Historic Data: 2019-2020   |   Base Year: 2021   |   Forecast Period: 2022-2028

Analysis By Product and Service (Equipment, Consumables, Service, and Software), Sample (Blood Products, Human Tissues, Cell Lines, and Others), and Application (Regenerative Medicine, Life Science Research, and Clinical Research)


No. of Pages: 162    |    Report Code: TIPRE00027967    |    Category: Life Sciences

Middle East and Africa Biobanks Market
Buy Now

The biobanks market in Middle East & Africa is expected to grow from US$ 113.66 million in 2021 to US$ 1 168.76 million by 2028; it is estimated to grow at a CAGR of 5.8% from 2021 to 2028.

Five years ago, genomic sequencing was restricted to the research environment. Genomic sequencing is rapidly transitioning into clinical practice, and implementation into healthcare systems has been supported by substantial government investments. The national genomic-medicine initiatives are driving transformative change under real-life conditions while simultaneously addressing barriers to implementation and gathering evidence for broader adoption, thereby driving the market growth. In genomic research on infectious diseases and their hosts, biobanks are significant resources. The availability of large biobanks is necessary for population genomics. Data from biobanks helps understand the etiology of multifactorial diseases caused by mutations in a range of genes and the influence of environmental variables and lifestyle on world-wide population. Therefore, the importance of biobanking as a research infrastructure component is expanding. Biobanks have also cleared the path for personalized medicine to evolve, particularly the production of tailored medications. The integration, analysis, and interpretation of data from biobanks play a significant role in understanding genetic susceptibilities to infectious diseases. Thus, the continuous funding in genomics by the manufacturers and governments and ongoing genomic research activities drive the growth of the biobanks market.

 

In Middle East & Africa region South Africa Saudi Arabia, and UAE are some of the worst affected countries. Economic uncertainties and ongoing conflicts are worsening the condition in the region. For instance, countries such as Syria, Libya, and Yemen are suffering violent conflicts and cannot implement robust public health measures. Iran was in deep economic recession due to the US sanctions. Also, the major source of economic stabilization in Middle East countries is oil production and export. However, the recent pandemic is causing turbulence to the economies of the Middle East. A sudden drop in domestic and external demand for goods and products, especially crude oil, and halted production due to labor shortage, are major impacts observed in the region. The Covid19 pandemic has brought new opportunities to biobanks as the importance of medical research has been brought to the forefront of the general public. Biobanks are currently well connected with other healthcare professionals and are building a more robust network to deal with future global crises. However, the availability of biobanks is not always guaranteed in the future. Prior to the pandemic, many biobanks had limited resources to maintain infrastructure, equipment, and staff. Suppressing the pandemic could dramatically reduce the public funding currently available, forcing biobanks to look for alternative sources of funding. These factors are projected to boost the growth of Middle East & Africa biobanks market.

 

With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the Middle East & Africa biobanks market. The Middle East & Africa biobanks market is expected to grow at a good CAGR during the forecast period.

 

Middle East & Africa Biobanks market Revenue and Forecast to 2028 (US$ Million)

 
Middle East & Africa Biobanks market Revenue and Forecast to 2028 (US$ Million)   

Middle East & Africa Biobanks Market Segmentation

 

Middle East & Africa Biobanks Market – By

Product and Service

  • Equipment

    • Storage Equipment
    • Sample Analysis Equipment
    • Sample Processing Equipment
    • Sample Transport Equipment
  • Consumables

    • Storage Consumables
    • Analysis Consumables
    • Processing Consumables
    • Collection Consumables
  • Service

    • Storage Services
    • Processing Services
    • Transport Services
    • Supply Services
  • Software

Middle East & Africa Biobanks Market – By

Sample

  • Blood Products
  • Human Tissues
  • Cell Lines
  • Others

Middle East & Africa Biobanks Market – By Application

  • Regenerative Medicine
  • Life Science Research
  • Clinical Research

Middle East & Africa Biobanks Market – By

Country

  • Saudi Arabia
  • South Africa
  • UAE
  • Rest of MEA

Middle East & Africa Biobanks Market – Companies Mentioned

  • THERMO FISHER SCIENTIFIC INC.
  • Tecan Trading AG
  • QIAGEN
  • Hamilton Company
  • Avantor, Inc.
  • MICRONICS JAPAN CO., LTD.
  • BD
  • Taylor-Wharton
  • Brooks Automation, Inc.
  • Promega Corporation
  • SciSafe Inc.     

Middle East and Africa Biobanks Strategic Insights

Strategic insights for the Middle East and Africa Biobanks provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.

strategic-framework/middle-east-and-africa-biobanks-market-strategic-framework.webp
Get more information on this report

Middle East and Africa Biobanks Report Scope

Report Attribute Details
Market size in 2021 US$ 113.66 Million
Market Size by 2028 US$ 1 168.76 Million
Global CAGR (2021 - 2028) 5.8%
Historical Data 2019-2020
Forecast period 2022-2028
Segments Covered By Product and Service
  • Equipment
  • Consumables
  • Service
  • Software
By Sample
  • Blood Products
  • Human Tissues
  • Cell Lines
By Application
  • Regenerative Medicine
  • Life Science Research
  • Clinical Research
Regions and Countries Covered Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • THERMO FISHER SCIENTIFIC INC.
  • Tecan Trading AG
  • QIAGEN
  • Hamilton Company
  • Avantor, Inc.
  • MICRONICS JAPAN CO., LTD.
  • BD
  • Taylor-Wharton
  • Brooks Automation, Inc.
  • Promega Corporation
  • Get more information on this report

    Middle East and Africa Biobanks Regional Insights

    The geographic scope of the Middle East and Africa Biobanks refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.

    geography/middle-east-and-africa-biobanks-market-geography.webp
    Get more information on this report

    The List of Companies - Middle East and Africa Biobanks Market

    1. THERMO FISHER SCIENTIFIC INC.
    2. Tecan Trading AG
    3. QIAGEN
    4. Hamilton Company
    5. Avantor, Inc.
    6. MICRONICS JAPAN CO., LTD.
    7. BD
    8. Taylor-Wharton
    9. Brooks Automation, Inc.
    10. Promega Corporation
    11. SciSafe Inc.
    Frequently Asked Questions
    How big is the Middle East and Africa Biobanks Market?

    The Middle East and Africa Biobanks Market is valued at US$ 113.66 Million in 2021, it is projected to reach US$ 1 168.76 Million by 2028.

    What is the CAGR for Middle East and Africa Biobanks Market by (2021 - 2028)?

    As per our report Middle East and Africa Biobanks Market, the market size is valued at US$ 113.66 Million in 2021, projecting it to reach US$ 1 168.76 Million by 2028. This translates to a CAGR of approximately 5.8% during the forecast period.

    What segments are covered in this report?

    The Middle East and Africa Biobanks Market report typically cover these key segments-

    • Product and Service (Equipment, Consumables, Service, Software)
    • Sample (Blood Products, Human Tissues, Cell Lines)
    • Application (Regenerative Medicine, Life Science Research, Clinical Research)

    What is the historic period, base year, and forecast period taken for Middle East and Africa Biobanks Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Middle East and Africa Biobanks Market report:

  • Historic Period : 2019-2020
  • Base Year : 2021
  • Forecast Period : 2022-2028
  • Who are the major players in Middle East and Africa Biobanks Market?

    The Middle East and Africa Biobanks Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • THERMO FISHER SCIENTIFIC INC.
  • Tecan Trading AG
  • QIAGEN
  • Hamilton Company
  • Avantor, Inc.
  • MICRONICS JAPAN CO., LTD.
  • BD
  • Taylor-Wharton
  • Brooks Automation, Inc.
  • Promega Corporation
  • SciSafe Inc.
  • Who should buy this report?

    The Middle East and Africa Biobanks Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the Middle East and Africa Biobanks Market value chain can benefit from the information contained in a comprehensive market report.

    Available Report Formats

    pdf-format excel-format pptx-format
    Buy Now